Technosphere insulin suppresses endogenous glucose production earlier than a rapid-acting analogue (lispro) and an inhaled insulin (Exubera®)

被引：0

作者：

Potocka, E.

Hovorka, R. ^{[1
]}

Baughman, R.

Umpleby, M. ^{[2
]}

Diaz, M.

Chen, R.

Cassidy, J.

Boss, A.

Richardson, P.

机构：

[1] Univ Cambridge, Metab Res Labs, Cambridge CB2 1TN, England

[2] Univ Surrey, Guildford GU2 5XH, Surrey, England

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

952

引用

页码：S374 / S374

页数：1

共 50 条

[1] AFRESA™ Suppresses Endogenous Glucose Production Earlier Than a Rapid-Acting Analog (Lispro) and Inhaled Exubera®
Potocka, Elizabeth
Hovorka, Roman
Baughman, Robert A.
Umpleby, Margot
Diaz, Mella Louise M.
Chen, Ru
Boss, Anders H.
Richardson, Peter C.
[J]. DIABETES, 2009, 58 : A61 - A61
[2] TECHNOSPHERE INSULIN PROVIDES BETTER EARLY POSTPRANDIAL GLUCOSE CONTROL THAN SUBCUTANEOUS RAPID-ACTING ANALOGUE
Grant, M.
Pompilio, F.
Sharma, G.
Zaveri, N.
Krueger, J.
Kendall, D.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A44 - A45
[3] Technosphere insulin provides better early postprandial glucose control than s.c. rapid-acting analogue
Grant, M.
Pompilio, F.
Sharma, G.
Zaveri, N.
Krueger, J.
Kendall, D.
[J]. DIABETOLOGIA, 2019, 62 : S94 - S94
[4] Usefulness of rapid-acting insulin lispro in CSII
Yanagisawa, K
Tuchida, KI
Endo, M
Masuda, H
Makita, Z
Koike, T
[J]. DIABETES, 2001, 50 : A446 - A446
[5] Technosphere Insulin Provides Better Early Postprandial Glucose Control than Subcutaneous Rapid-Acting Analog
Grant, Marshall L.
Pompilio, Frank
Sharma, Gaurav
Krueger, John A.
Kendall, David M.
Zaveri, Nadia
[J]. DIABETES, 2019, 68
[6] Effect of rapid-acting insulin Lispro® on brittle diabetes
Juang, JH
Wu, WP
[J]. DIABETES, 2001, 50 : A439 - A439
[7] A 3 month comparison in type 1 diabetes of inhaled Technosphere®/Insulin (TI) to sc administered rapid-acting insulin analogue (RAA) as prandial insulin in a basal/prandial regimen
Boss, Anders H.
Baughman, Robert A.
Evans, Shawna H.
Firsov, Igor
Kramer, David A.
Richardson, Peter
[J]. DIABETES, 2006, 55 : A97 - A97
[8] Patient Reported Outcomes in Adults with Type 1 Diabetes Using Mealtime AFRESA™ (Inhaled Technosphere® Insulin) or Rapid-Acting Insulin with Basal Insulin
Rubin, Richard R.
Peyrot, Mark
[J]. DIABETES, 2009, 58 : A484 - A484
[9] Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
Garg, SK
Ellis, SL
Ulrich, H
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 643 - 651
[10] Preclinical safety pharmacology studies on the rapid-acting insulin analogue insulin aspart
Dall, V
[J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1999, 49 (05): : 463 - 470

← 1 2 3 4 5 →